Early Screening for Gestational Diabetes Mellitus in a Low Risk Population

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21-39
SponsorNational University Hospital, Singapore

About this trial

This new feasibility pilot study aims to refine the design and protocols for a larger trial that will investigate the potential benefits of early oral glucose tolerance test (OGTT) screening in a population traditionally defined as low-risk for development of gestational diabetes. The study will evaluate its potential effectiveness in reducing the risks of neonatal morbidity/mortality and obstetric complications. Additionally, a machine learning algorithm to predict gestational diabetes mellitus (GDM) risk based on routinely obtained clinical information at pregnancy booking, and minimally invasive methods, such as continuous glucose monitoring (CGM) and gingival crevicular fluid (GCF) sampling, are being explored to predict the risk of hyperglycaemia. This study aims to investigate the utility of early pregnancy screening to enable timely detection and management of early gestational diabetes development in a low-risk population, ultimately promoting better health outcomes for mothers and their babies.

Eligibility criteria

Qualifiers

Pregnant women aged 21-39 years at recruitment

Singleton pregnancy

Less than 16 weeks pregnant at recruitment

Intend to receive antenatal care and give birth at the National University Hospital

Disqualifiers

Known pre-existing type 1 or type 2 diabetes mellitus at recruitment

Taking systemic steroid medication or metformin

Participation in another intervention trial

Trial design

Treatments tested in this trial

  • Early OGTT Results Revealed

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators

National University Hospital, Singapore

Lead sponsor

National University of Singapore

Collaborator

Agency for Science, Technology and Research

Collaborator